Do You Think We're Facing Challenges With New Modalities?

As you talk about novel modalities, approaches out there that are really maturing now. Do you have any concern or any thoughts about our projected uptake within the marketplace for these modalities versus the actual reality of it? I think we're at a different point today in terms of the readiness of the market to accept these new technologies. There's still a lot of work to be done, but at least there's a recognition that these new modalities require a high touch,. It's a high touch of education, not only with the patients on the advocacy groups, but with prescribers as well.